Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients with Intermediate-Risk Cervical Cancer By Ogkologos - April 7, 2025 783 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a cohort study conducted at Commission on Cancer accredited centres across the US Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR New Areolar Incision Technique Leaves Almost No Scars for Breast Cancer... December 7, 2020 Opinion: “There’s cause for optimism in 2021 and beyond” December 30, 2020 Savolitinib Shows Promise in Pulmonary Sarcomatoid Carcinoma and Other METex14-positive NSCLC... June 23, 2021 ESMO’s Expert Consensus: Do Not Discontinue or Delay Cancer Treatment That... July 31, 2020 Load more HOT NEWS Online Dating During COVID-19 and Cancer: What to Know Cancer Surgery Unexpectedly Canceled for Mother of Two, Who Says It’s... FDA Approves Pralsetinib for Lung Cancer with RET Gene Fusions Do Frequent Follow-Up Tests Benefit Colorectal Cancer Survivors?
